Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Defiance Autism Impact ETF

ASD

28.2630.15% ( +0.043 )

Closed: Aug 21, 16:00:00 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts WikiWiki RatingsRatings CompositionComposition DividendsDividends

LongbridgeAI

B. Metzler seel. Sohn & Co. AG Takes $3.60 Million Position in Repligen Corporation $RGEN
Market Beat·1 day ago, 02:20 AM
RGEN+0.47%
Repligen CEO Olivier Loeillot disposes of 5,426 common shares worth $976,680
PUBT·2 days ago, 03:07 PM
RGEN+0.47%
Mitsubishi UFJ Asset Management Co. Ltd. Purchases Shares of 148,853 Revvity Inc. $RVTY
Market Beat·2 days ago, 04:12 AM
RVTY+0.50%8306
Boehringer again rises up rare disease reputation rankings
Fiercepharma·2 days ago, 01:52 AM
BMRN-1.45%AZN+0.91%
Revvity Inc. Stock Outperforms Competitors On Strong Trading Day
MarketWatch Automated·Aug 20 at 04:32 PM
RVTY+0.50%
Repligen (NASDAQ:RGEN) Stock Price Up 5.9% - Here's Why
Market Beat·Aug 20 at 12:20 PM
RGEN+0.47%
Revvity Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
MarketWatch Automated·Aug 19 at 04:13 PM
RVTY+0.50%
Revvity (NYSE:RVTY) Reaches New 52-Week High - Time to Buy?
Market Beat·Aug 19 at 11:00 AM
RVTY+0.50%
BioMarin to acquire Alesta Therapeutics for $275 million for potential rare bone disease treatment
MSN·Aug 19 at 10:32 AM
BMRN-1.45%
BioMarin spends up to $490m for Alesta’s bone disease candidate
Pharmaceutical Technology·Aug 19 at 08:55 AM
BMRN-1.45%
This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
benzinga_article·Aug 19 at 06:55 AM
ALNY+3.02%BMRN-1.45%
Revvity Inc. Stock Underperforms Tuesday When Compared To Competitors
MarketWatch Automated·Aug 18 at 04:15 PM
RVTY+0.50%
The Bull Case For Repligen (RGEN) Could Change Following Raised Guidance On Q2 Outperformance - Learn Why
Simplywall·Aug 18 at 02:38 PM
RGEN+0.47%
LifeStance Health Group (NASDAQ:LFST) Hits New 52-Week High - Here's What Happened
Market Beat·Aug 18 at 09:00 AM
LFST-1.42%
This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
benzinga_article·Aug 18 at 07:45 AM
BZ+1.08%SSMR+6.82%